Page 856 - Cote clinical veterinary advisor dogs and cats 4th

Heart Failure, Chronic 412.e1

ADDITIONAL SUGGESTED RELATED CLIENT EDUCATION
READINGS SHEETS
VetBooks.ir Boswood A, et al: Effect of pimobendan in dogs Consent to Perform Echocardiography Diseases and Disorders
with preclinical myxomatous mitral valve disease
Dilated Cardiomyopathy
and cardiomegaly: the EPIC study—a randomized
clinical trial. J Vet Intern Med 30(6):1765-1779,
2016. Heart Failure
How to Count Respirations and Monitor
Chetboul V, et al: Comparative adverse cardiac effects Respiratory Effort
of pimobendan and benazepril monotherapy in Mitral/Tricuspid Regurgitation Due to Myxo-
dogs with mild degenerative mitral valve disease: matous Heart Valve Disease
a prospective, controlled, blinded, and randomized
study. J Vet Intern Med 21(4):742-753, 2007.
Chetboul V, et al: Effect of benazepril on survival and
cardiac events in dogs with asymptomatic mitral
valve disease: a retrospective study of 141 cases. J
Vet Intern Med 22:905-914, 2008.
Ettinger SJ, et al: Effects of enalapril maleate on
survival of dogs with naturally acquired heart
failure. The Long-Term Investigation of Veterinary
Enalapril (LIVE) study group. J Am Vet Med Assoc
213(11):1573-1577, 1998.
Häggström J, et al: Effect of pimobendan or bena-
zepril hydrochloride on survival times in dogs
with congestive heart failure caused by naturally
occurring myxomatous mitral valve disease: the
QUEST study. J Vet Intern Med 22:1124-1135,
2008.
Häggström J, et al: An update on treatment and
prognostic indicators in canine myxomatous
mitral valve disease. J Small Anim Pract 50(suppl
1):25-33, 2009.
Jeunesse E, et al: Effect of spironolactone on diuresis
and urine sodium and potassium excretion in
healthy dogs. J Vet Cardiol 9(2):63-68, 2007.
Keene BW, et al: Management of heart failure in
dogs. In Bonagura JD, et al, editors: Kirk’s Current
veterinary therapy XIV, St. Louis, 2009, Saunders,
pp 769-780.
Luis Fuentes V: Management of feline myocardial
disease. In Bonagura JD, et al, editors: Kirk’s
Current veterinary therapy XIV, St. Louis, 2009,
Saunders, pp 809-815.
MacDonald KA, et al: Effect of spironolactone on
diastolic function and left ventricular mass in Maine
coon cats with familial hypertrophic cardiomyopa-
thy. J Vet Intern Med 22(2):335-341, 2008.
Ouellet M, et al: Effect of pimobendan on echocar-
diographic values in dogs with asymptomatic mitral
valve disease. J Vet Intern Med 23(2):258-263,
2009.
Sisson D, et al: Management of heart failure:
principles of treatment, therapeutic strategies, and
pharmacology. In Fox PR, et al, editors: Textbook
of canine and feline cardiology, ed 2, Philadelphia,
1999, Saunders, pp 216-250.
The BENCH (BENazepril in Canine Heart disease)
Study Group: Long-term tolerability of benazepril
in dogs with congestive heart failure. J Vet Cardiol
6(1):7-13, 2004.

www.ExpertConsult.com